Etoricoxib | Composition:
Etoricoxib –A COX-2 inhibitor (selective inhibitor).
This drug selectively inhibits the enzymes as COX-2 and its isoform-2 for reducing the synthesis of prostaglandins from the arachidonic acid.
The most recent indications for this drug are gout, acute pain conditions, and arthritic pain. This drug possesses both antipyretic and analgesic properties.
In comparison to the other available NSAIDs, this drug is more favorable to the gastric safety profile due to its composition and mechanism of action.
Indications:
The most common indications of this drug are:
- Osteoarthritis (OA, RA, AS, and JIA)
- Acute and chronic back pain
- Knee osteoarthritis mainly
- Musculoskeletal pain and disorders
- Pain due to muscle, tendon, and ligament injury
- Post-operative pain
- Trauma and fracture pain
Functioning:
Chronic low back pain or back pain is the most debilitating disorder in almost 30-40% of the population. Acute conditions can subside within few days, but chronic conditions take a long time to give up. In the case of chronic low back pain, ETOB90 can be a more promising drug to lessen the recovery time.
Etoricoxib itself is a combination of thiocolchicoside and etoricoxib, which is an NSAID. It can help in relieving the pain and inflammation in the back area. Along with it, this drug can help in all types of inflammations due to arthritis.
Prescription information:
Dosage:
One tablet of ETOB90 contains:
- 120 mg of Etoricoxib
You can use ETOB90 medicine twice a day according to your condition.
- Do not exceed its usage more than two times in one day.
- If you are experiencing pain, you can use it to relieve pain in a shorter time.
Side-effects:
There are no absolute side effects of this drug. However, patients can suffer from mild symptoms of nausea.
Contraindications:
There are no absolute contraindications of this drug. However, lactating and pregnant women should take care while having this drug.
Download Here – Prescribing information
References:
- https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1756-185X.2010.01468.x
- https://link.springer.com/article/10.2165/00003495-200262180-00006
- https://journals.sagepub.com/doi/abs/10.1016/j.otohns.2007.10.022
- https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004309.pub4/abstract
- https://europepmc.org/article/med/15319795
I have read so many content on the topic of the blogger
lovers however this paragraph is genuinely a pleasant piece of writing, keep it up.
Fabulous, what a weblog it is! This website provides valuable data to us, keep it up.